Respiratory Distress Syndrome Adult
📧 Sign up to get email alerts when something new happens for Respiratory Distress Syndrome Adult.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome [Phase 2]
Phase 2 trial update for HLCM051 (MultiStem) assessing efficacy and safety in adult pneumonic acute respiratory distress syndrome has been c…
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19 [Phase 2]
Phase 2 trial of USB002 for respiratory distress due to COVID-19 was terminated; results posted in December 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Telmisartan in Respiratory Failure Due to COVID-19 [Phase 2]
Phase 2 clinical trial evaluating telmisartan for respiratory failure in COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Roflumilast as add-on Therapy in Early Cases of ARDS [Phase 2]
Phase 2 trial evaluating roflumilast as add-on therapy in early acute respiratory distress syndrome (adult).
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 [Phase 2]
Phase 2 trial update for Veru-111 in adults with severe respiratory distress syndrome related to COVID-19 has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 [Phase 3]
A Phase 3 clinical trial evaluating dexamethasone for severe acute respiratory distress syndrome induced by COVID-19 was terminated.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial [Phase 3]
A multicenter Phase 3 randomized trial evaluated dexamethasone for COVID-19-related ARDS but was terminated before completion.
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS [Phase 2]
Phase 2 trial evaluating safety and efficacy of BIO-11006 inhalation solution in adults with respiratory distress syndrome (ARDS) has comple…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Treprostinil Sodium Inhalation for Patients At High Risk for ARDS [Phase 2]
Phase 2 trial update for treprostinil sodium inhalation in adults at high risk for ARDS; study terminated with results posted.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: Comparison Study of High Frequency Percussive Ventilation With Conventional Ventilation [Phase 2, Phase 3]
Trial update indicates the Phase 2/Phase 3 study comparing high frequency percussive ventilation with conventional ventilation for adult res…
-
CLINICAL_TRIALS research · 2013-11-05Clinical Trial Update: Continuous Positive Airway Pressure (CPAP) Ventilation Using a Novel Full-Face Mask Versus Conventional Helmet [NA]
ClinicalTrials.gov update indicates the study comparing a novel full-face CPAP mask with a conventional helmet for respiratory support has b…
-
CLINICAL_TRIALS trial_result · 2007-03-26Clinical Trial Update: Effect of Positive Expiratory Pressure on Right Ventricular Function in Patients With Respiratory Distress Syndrome [NA]
This clinical trial update reports on the effects of positive expiratory pressure on right ventricular function in adults with respiratory d…